Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)

Completed

Conditions studied: Atrial Fibrillation

In brief

This prospective study aims to examine the association of specific genetic variants (single nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary vein triggers (NPVT) as well as ablation-outcome in AF patients

Key facts

Study ID

NCT01751607

Run by

Texas Cardiac Arrhythmia Research Foundation

People needed

400

Starts

2012-12-01

Expected to finish

2014-08-01

Last updated by the study team

2014-09-05

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• AF patients undergoing catheter ablation
• Able and willing to provide written informed consent

You may not qualify if…

• Previous left atrial catheter ablation or MAZE procedure
• Reversible causes of atrial arrhythmia such as hyperthyroidism, sarcoidosis, pulmonary embolism etc

Where it is running

• Texas Cardiac Arrhythmia Institute, St. david's Medical Center — Austin, Texas, United States
• Texas Cardiac arrhythmia Institute, St. David's Hospital — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.